In the current study, we observed immunoreactivity for both ASCL1 and NEUROD1 in almost half of the SCLC tissue samples, which motivated us to characterise ASCL1/NEUROD1 double-positive SCLC. Here, NEUROD1 is linked to small cell lung carcinoma.